Addex`s eyelid data fail to make clear case for spasm expansion
28 May 2022 //
FIERCEBIOTECH
Addex Provides Update on Dipraglurant Blepharospasm Phase 2 Feasibility Study
26 May 2022 //
GLOBENEWSWIRE
Addex Therapeutics initiates phase 2b/3 study with dipraglurant for dyskinesia
02 Jul 2021 //
PHARMABIZ
Addex Therapeutics Initiates Pivotal Phase 2b/3 Study with Dipraglurant
29 Jun 2021 //
GLOBENEWSWIRE